相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hyperosmolar hyperglycemic state in advanced amyotrophic lateral sclerosis
Toshio Shimizu et al.
AMYOTROPHIC LATERAL SCLEROSIS (2011)
Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats
Wei Jing Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases
Kathryn A. Frankola et al.
CNS & Neurological Disorders-Drug Targets (2011)
Neuroprotective properties of GLP-1: theoretical and practical applications
Jens Juul Holst et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Glucagon-like Peptide-1 Analogues for Type 2 Diabetes Mellitus Current and Emerging Agents
Baptist Gallwitz
DRUGS (2011)
The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
Ruben Isacson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Emerging drugs for amyotrophic lateral sclerosis
Ali Aamer Habib et al.
EXPERT OPINION ON EMERGING DRUGS (2011)
Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia
Shinichiro Teramoto et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
Lionel M. Igaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
TDP-43-Based Animal Models of Neurodegeneration: New Insights into ALS Pathology and Pathophysiology
Iga Wegorzewska et al.
NEURODEGENERATIVE DISEASES (2011)
Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1(G93A)) transgenic amyotrophic lateral sclerosis (ALS) mice
Jae Chul Lee et al.
NEUROLOGICAL RESEARCH (2011)
Glucagon-like Peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation
Xiao-Yun Xie et al.
MEDICAL SCIENCE MONITOR (2011)
In Vivo Imaging Reveals Distinct Inflammatory Activity of CNS Microglia versus PNS Macrophages in a Mouse Model for ALS
Payam Dibaj et al.
PLOS ONE (2011)
GFAP in health and disease
J. Middeldorp et al.
PROGRESS IN NEUROBIOLOGY (2011)
Impaired glucose tolerance in patients with amyotrophic lateral sclerosis
Pierre-Francois Pradat et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis
Aaron C. Pawlyk et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Motor neuron-immune interactions: the vicious circle of ALS
Ana G. Barbeito et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Pharmacological Characterization of Human Incretin Receptor Missense Variants
Jean-Philippe Fortin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
Daryl A. Bosco et al.
NATURE NEUROSCIENCE (2010)
Glucagon-like peptide-1 protects NSC-34 motor neurons against glucosamine through Epac-mediated glucose uptake enhancement
Jung-Geun Lim et al.
NEUROSCIENCE LETTERS (2010)
Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
Talib Abbas et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Determination of high-affinity choline uptake (HACU) and choline acetyltransferase (ChAT) activity in the same population of cultured cells
Balmiki Ray et al.
BRAIN RESEARCH (2009)
Exendin-4 Improves Glycemic Control, Ameliorates Brain and Pancreatic Pathologies, and Extends Survival in a Mouse Model of Huntington's Disease
Bronwen Martin et al.
DIABETES (2009)
Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
Sehee Kim et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Microglia in ALS: The Good, The Bad, and The Resting
Jenny S. Henkel et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Decline in Daily Running Distance Presages Disease Onset in a Mouse Model of ALS
Daniel A. Bruestle et al.
NEUROMOLECULAR MEDICINE (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Iga Wegorzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications
Mauro Cozzolino et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Glucagon-like peptide I receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease
Alexander Harkavyi et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease
Goran Bertilsson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences
Shinsuke Kato
ACTA NEUROPATHOLOGICA (2008)
Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation
Samer Abou Ezzi et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Amyotrophic lateral sclerosis:: all roads lead to Rome
Jose-Luis Gonzalez de Aguilar et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model
Caroline Rouaux et al.
JOURNAL OF NEUROSCIENCE (2007)
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Makiko Nagai et al.
NATURE NEUROSCIENCE (2007)
GLP-1 receptor expression in human tumors and human normal tissues:: Potential for in vivo targeting
Meike Koerner et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model
Francesco Paolo Di Giorgio et al.
NATURE NEUROSCIENCE (2007)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice
Yaoming Wang et al.
JOURNAL OF NEUROSCIENCE (2007)
ALS:: A disease of motor neurons and their nonneuronal neighbors
Sverine Boillee et al.
NEURON (2006)
Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
Takashi Iwai et al.
NEUROSCIENCE RESEARCH (2006)
Axonal excitability properties in amyotrophic lateral sclerosis
Steve Vucic et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Stimulation of pancreatic β-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways
BN Friedrichsen et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Piera Pasinelli et al.
NATURE REVIEWS NEUROSCIENCE (2006)
A randomized, open-label, crossover study examining the effect of injection site on bioavallability of exenatide (synthetic exendin-4)
F Calara et al.
CLINICAL THERAPEUTICS (2005)
The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
E Alvarez et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Astrogliosis in ALS: possible interpretations according to pathogenetic hypotheses
D Schiffer et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
Insulin and neurodegenerative disease: shared and specific mechanisms
S Craft et al.
LANCET NEUROLOGY (2004)
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
LR Fischer et al.
EXPERIMENTAL NEUROLOGY (2004)
Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells
A Nakagawa et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2004)
VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?
D Lambrechts et al.
TRENDS IN MOLECULAR MEDICINE (2004)
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
M Azzouz et al.
NATURE (2004)
Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration
WA Banks et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron
T Perry et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Entry of exendin-4 into brain is rapid but may be limited at high doses
AJ Kastin et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
MA Luque et al.
JOURNAL OF ENDOCRINOLOGY (2002)
A novel neutrotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation
N Shibata
NEUROPATHOLOGY (2001)
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
MW Li et al.
SCIENCE (2000)
分享论文
